Lifecore Biomedical (LDE) Income Statement
Lifecore Biomedical Income Statement
Last quarter (Q4 2026), Lifecore Biomedical's total revenue was $34.17M, a decrease of 6.25% from the same quarter last year. In Q4, Lifecore Biomedical's net income was $-6.16M. See Lifecore Biomedical’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | May 25 | May 24 | Aug 23 | May 22 |
|---|---|---|---|---|---|
| $ 129.46M | $ 128.87M | $ 128.26M | $ 103.27M | $ 111.27M | |
| $ 40.61M | $ 40.30M | $ 41.85M | $ 27.98M | $ 39.07M | |
| $ 41.87M | $ 57.54M | $ 50.69M | $ 49.78M | $ 50.86M | |
| Depreciation and Amortization | $ 9.50M | $ 8.03M | $ 7.95M | $ 13.18M | $ 18.06M |
| $ 8.24M | $ -8.81M | $ 35.56M | $ -33.17M | $ 12.84M | |
| $ -1.26M | $ -17.25M | $ -8.84M | $ -21.80M | $ -11.79M | |
| $ -28.96M | $ -21.43M | $ 18.36M | $ -42.13M | $ -8.90M | |
| $ -30.21M | $ -38.67M | $ 9.51M | $ -63.93M | $ -20.69M | |
| $ -30.79M | $ -38.72M | $ 12.01M | $ -99.56M | $ -116.72M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.92 | $ -1.27 | $ 0.39 | $ -3.32 | $ -3.97 |
| Diluted EPS | $ -0.93 | $ -1.27 | $ 0.33 | $ -3.32 | $ -3.97 |
| Weighted Average Shares Outstanding | 33.26M | 34.82M | 30.47M | 29.96M | 29.47M |
| Weighted Average Shares Outstanding (Diluted) | 37.37M | 34.82M | 36.66M | 29.96M | 29.47M |
Currency in USD
